Purpose: Metabolic disorders are known to cause poor sleep quality. However, there is not much research about the association of diabetic complications and poor sleep quality. Our aim was to find out which diabetic complications are associated with poor sleep quality in type 2 diabetes (T2D).
Methods: In this cross-section study, sleep quality of 151 T2D patients were assessed by using the Pittsburgh Sleep Quality Index (PSQI) questionnaire. PSQI score was interpreted as good sleep quality for ≤ 5 and poor sleep quality for > 5. Microvascular complications were assessed with the presence of diabetic retinopathy, diabetic polyneuropathy (DPN) and microalbuminuria. Macrovascular complications were assessed with ankle-brachial index, pulse wave velocity, and carotid intima-media thickness.
Results: Fasting c-peptide, insulin, triglyceride (TG) and waist-hip ratio (WHR) were higher in the poor sleep quality group. Among the complications, the proportion of DPN was higher in the poor sleep quality group (31.7% vs. 15.2%, p=0.020). Other diabetic complications did not show a significant difference between both groups (Table). After adjustment for sex, age, usage of insulin, TG, WHR and DPN, fasting c-peptide was the only significant marker for poor sleep quality in T2D (OR = 2.207, p = 0.048).
Conclusion: DPN was higher in the poor sleep quality group. Other diabetic complications showed no significant difference in both groups.
D. Choi: None. B. Kim: None. C. Jung: None. C. Kim: None. S. Kang: None. J. Mok: None.